KimAnna(Reiss)Reiss BinderMD

PubMed

• Targeting BRCA and PALB2 in Pancreatic Cancer.
  Anbil, S., Reiss, K.> ;Current Treatment Options in Oncology. 2024 Mar 1
• The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 after Progression on Rucaparib.
  Arielle Yablonovitch, Jacob E Till, Jennifer Yen, Lesli A Kiedrowski, Ryan Hood, Mark H O'Hara, Ursina Teitelbaum, Erica L Carpenter, Katherine Nathanson, Susan M Domc...> ;Clinical Cancer Research. 2023 Dec 15
• Analysis of BRCA1- and BRCA2-Related Pancreatic Cancer and Survival.
  Ben Boursi, E Paul Wileyto, Ronac Mamtani, Susan M Domchek, Talia Golan, Ryan Hood, Kim A Reiss> ;JAMA Network Open. 2023 Nov 1
• Tumor Differentiation as a Prognostic Marker in Clinically Staged T1bN0 Esophageal Adenocarcinoma.
  Ofer Margalit, Einat Shacham-Shmueli, Gal Strauss, Yu-Xiao Yang, Yaacov R Lawrence, Alon Ben Nun, Idan Levy, Kim A Reiss, Talia Golan, Naama Halpern, Dan Aderka, Bruce...> ;Cancer Investigation. 2023 Sep 1
• 2 citations
  BiallelicLoss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in GermlineCarriers.
  Dylane Wineland, Anh N Le, Ryan Hausler, Gregory Kelly, Emanuel Barrett, Heena Desai, Bradley Wubbenhorst, John Pluta, Paul Bastian, Heather Symecko, Kurt D'Andrea, Ab...> ;JCO Precision Oncology. 2023 Aug 1
• Advancements in Systemic Therapy for Pancreatic Cancer.
  Timothy J Brown, Kim A Reiss, Mark H O'Hara> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023 May 1
• 1 citations
  A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence.
  Thatcher R Heumann, Marina Baretti, Elizabeth A Sugar, Jennifer N Durham, Sheila Linden, Tamara Y Lopez-Vidal, James Leatherman, Leslie Cope, Anup Sharma, Colin D Week...> ;Clinical Epigenetics. 2022 Dec 3
• Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma.
  Phyllis A Gimotty, Jacob E Till, Shirsa Udgata, Naomi Takenaka, Stephanie S Yee, Michael J LaRiviere, Mark H O'Hara, Kim A Reiss, Peter O'Dwyer, Bryson W Katona, Danie...> ;Oncotarget. 2022 Nov 2
• 1 citations
  PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma.
  William J Chapin, Kim A Reiss> ;Hematology/oncology Clinics of North America. 2022 Oct 1
• 6 citations
  Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer.
  Thomas B Karasic, Timothy J Brown, Charles Schneider, Ursina R Teitelbaum, Kim A Reiss, Tara C Mitchell, Ryan C Massa, Mark H O'Hara, Lisa DiCicco, Luis Garcia-Marcano...> ;The Oncologist. 2022 Sep 2
• 5 citations
  A Randomized Study of Olaparib or Placebo in Patients with Surgically Removed Pancreatic Cancer who have a BRCA1, BRCA2 or PALB2 Mutation (The APOLLO Trial).
  Martha E Teke, Areeba Saif, Carrie E Ryan, Stephanie C Lux, Jonathan M Hernandez, Kim A Reiss> ;Annals of Surgical Oncology. 2022 Sep 1
• 34 citations
  Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial.
  Kim A Reiss, Rosemarie Mick, Ursina Teitelbaum, Mark O'Hara, Charles Schneider, Ryan Massa, Thomas Karasic, Rashmi Tondon, Chioma Onyiah, Mary Kate Gosselin, Alyssa Do...> ;The Lancet. Oncology. 2022 Aug 1
• Correction to: Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma.
  Ofer Margalit, Shun Yu, Einat Shacham-Shmueli, Gal Strauss, Yu-Xiao Yang, Yaacov R Lawrence, Kim A Reiss, Talia Golan, Naama Halpern, Dan Aderka, Bruce Giantonio, Rona...> ;Journal of Cancer Research and Clinical Oncology. 2022 Jul 1
• Benefit for single-agent adjuvant chemotherapy in elderly patients with locally advanced gastric adenocarcinoma.
  Ofer Margalit, Shun Yu, Einat Shacham-Shmueli, Gal Strauss, Yu-Xiao Yang, Yaacov R Lawrence, Kim A Reiss, Talia Golan, Naama Halpern, Dan Aderka, Bruce Giantonio, Rona...> ;Journal of Cancer Research and Clinical Oncology. 2022 Jul 1
• 3 citations
  Multianalyte Prognostic Signature Including Circulating Tumor DNA and Circulating Tumor Cells in Patients With Advanced Pancreatic Adenocarcinoma.
  William J Chapin, Jacob E Till, Wei-Ting Hwang, Jennifer R Eads, Thomas B Karasic, Peter J O'Dwyer, Charles J Schneider, Ursina R Teitelbaum, Janae Romeo, Taylor A Bla...> ;JCO Precision Oncology. 2022 Jul 1
• 7 citations
  Cost-Effectiveness of a Risk-Tailored Pancreatic Cancer Early Detection Strategy Among Patients With New-Onset Diabetes.
  Louise Wang, Frank I. Scott, Ben Boursi, Kim A. Reiss, Sankey V. Williams, Henry A. Glick, Yu-Xiao Yang> ;Clinical Gastroenterology and Hepatology. 2021 Nov 2
• 1 citations
  THSB2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma.
  Phyllis A. Gimotty, Jacob Till, Shirsa Udgata, Naomi Takenaka, Stephanie S. Yee, Michael J. LaRiviere, Mark H. O'Hara, Kim A. Reiss, Peter O'Dwyer, Bryson W. Katona, D...> ;Oncotarget. 2021 Oct 26
• 8 citations
  Determinants of Homologous Recombination Deficiency in Pancreatic Cancer.
  Max M. Wattenberg, Kim A. Reiss> ;Cancers. 2021 Sep 21
• 24 citations
  Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer.
  Jada G. Hamilton, Heather Symecko, Kelsey Spielman, Kelsey Breen, Rebecca Mueller, Amanda Catchings, Magan Trottier, Erin E. Salo-Mullen, Ibrahim H Shah, Anna Arutyuno...> ;Genetics in Medicine. 2021 Jul 13
• 77 citations
  Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, BRCA2, or...
  Kim A. Reiss, Rosemarie Mick, Mark H. O'Hara, Ursina R. Teitelbaum, Thomas B. Karasic, Charles Schneider, Stacy Cowden, Traci Southwell, Janae Romeo, Natallia Izgur, Z...> ;Journal of Clinical Oncology. 2021 May 10
• 1 citations
  Alternatives to Perpetual Chemotherapy for Metastatic Pancreatic Cancer.
  Kim A. Reiss, Robert H. Vonderheide> ;Clinical Cancer Research. 2021 Apr 23
• 7 citations
  A Pilot Study of Galunisertib plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular Carcinoma
  Kim A. Reiss, Max M. Wattenberg, Nevena Damjanov, Elizabeth Prechtel Dunphy, Mona Jacobs-Small, M. Judy Lubas, James Robinson, Lisa DiCicco, Luis Garcia-Marcano, Micha...> ;Molecular Cancer Therapeutics. 2021 Feb 1
• 9 citations
  Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic ATM Alterations.
  Zain M. Hannan, Shun Yu, Susan M. Domchek, Ronac Mamtani, Kim A. Reiss> ;JNCI Cancer Spectrum. 2021 Jan 23
• 4 citations
  Comparative Effectiveness of Total Neoadjuvant Therapy Versus Standard Adjuvant Chemotherapy for Locally Advanced Rectal Cancer.
  Shun Yu, Ronac Mamtani, Mark H. O'Hara, P. J. O'Dwyer, Ofer Margalit, Bruce J. Giantonio, Einat Shacham Shmueli, Kim A. Reiss, Ben Boursi> ;Clinical Colorectal Cancer. 2021 Jan 22
• 1 citations
  Prognostic Implications of Tumor Differentiation in Clinical T1N0 Gastric Adenocarcinoma
  Ofer Margalit, Einat Shacham-Shmueli, Yu-Xiao Yang, Yaacov R. Lawerence, Idan Levy, Kim A. Reiss, Talia Golan, Naama Halpern, Dan Aderka, Bruce J. Giantonio, Ronac Mam...> ;The Oncologist. 2021 Jan 1
• Join now to see all

Lectures

• A randomized phase II trial of niraparib plus either nivolumab or ipilimumab in patients with advanced pancreatic cancer whose cancer has not progressed on platinum-ba... 
  2019 ASCO Annual Meeting - 6/1/2019